Business Wire

SEKISUI CHEMICAL: Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany and Korea

Share

The High Performance Plastics Company (President: Ikusuke Shimizu) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) has filed lawsuits for infringement of its European patent 2 017 237 (“EP ’237”), European patent 3 208 247 (“EP ’247”), European patent 3 357 888 (“EP ’888”) and European patent 3 392 222 (“EP ’222”) against Kuraray Europe GmbH (hereinafter “Kuraray Europe”), a subsidiary of Kuraray Co., Ltd., as the defendant before the District Courts Munich I (docket No. 7 O 12401/24, docket No. 7 O 12476/24 and docket No. 7 O 12477/24) and Mannheim (docket No. 2 O 92/24) in Germany.

The lawsuits based on EP ’237 and EP ’247 relating to sound control properties of a PVB Interlayer and based on EP ’888 relating to shrinkage properties of a PVB Interlayer owned by SEKISUI CHEMICAL and asserted before the District Court Munich I, seek, inter alia, injunctions against the manufacture and offering for sale etc. of “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol The Wedge Acoustic Shadeband” sound insulation wedge products manufactured and offered for sale by Kuraray Europe in Germany, as well as, inter alia, declaratory judgments on liability for damages.

The lawsuit based on EP ’222 relating to glossiness for a PVB Interlayer, owned by SEKISUI CHEMICAL and asserted before the District Court Mannheim, seeks, inter alia, an injunction against the manufacture and offering for sale etc. of “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol’ The Wedge Acoustic Shadeband” sound insulation wedge products manufactured and offered for sale by Kuraray Europe in Germany, as well as, inter alia, a declaratory judgement on liability for damages.

SEKISUI CHEMICAL has filed a patent infringement lawsuit against Kuraray Korea Ltd. (hereinafter “Kuraray Korea”), a subsidiary of Kuraray Co., Ltd., as the defendant in the Seoul Central District Court of Korea.

Based on the Korean patent for PVB Interlayer owned by SEKISUI CHEMICAL, the lawsuit seeks an injunction against the manufacture and sale, etc. in Korea of ‘Trosifol’ The Wedge Acoustic and ‘Trosifol’ The Wedge Acoustic Shadeband, sound insulation wedge products manufactured and sold by Kuraray Korea, and damages.

SEKISUI CHEMICAL regards its intellectual property rights as an important management resource. It will take strict action in cases where it determines that SEKISUI CHEMICAL Group’s intellectual property rights have been infringed.

About SEKISUI CHEMICAL Group

Headquartered in Japan, SEKISUI CHEMICAL CO., LTD. (TSE: 4204) and its subsidiaries make up the SEKISUI CHEMICAL Group. 26,000 employees in over 156 companies throughout 20 countries and regions aim to contribute to improving the lives of the people of the world and the earth’s environment. Thanks to a history of innovation, dedication and a pioneering spirit, SEKISUI CHEMICAL now holds leading positions in its three diverse business divisions as well as top global market share in interlayer film, foam products, conductive particles and more.

Disclaimer

This press release may contain forward-looking statements. Such forward-looking statements are based on current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements due to changes in global economic, business, competitive market and regulatory factors.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241101799415/en/

Contacts

SEKISUI CHEMICAL CO., LTD.
Corporate Communication Department
Email: kouhou@sekisui.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Announces Board Transitions and Management Update2.1.2025 14:00:00 EET | Press release

Kinaxis® Inc. (“Kinaxis ” or the “Company ”) (TSX: KXS), a global leader in end-to-end supply chain orchestration, has, effective January 1, appointed Lynn Loewen to the Company’s Board of Directors and member of the Audit Committee. Due to current commitments, Betsy Rafael will not be seeking re-election to the Board at the 2025 annual general meeting. “I’m pleased to add an exceptionally qualified Director in Lynn, who will ensure we maintain the strength of the audit oversight function, while bolstering the Board in a number of ways,” said Robert (Bob) Courteau, chair and interim chief executive officer. “Betsy has been an exceptional board member and we fully respect that she has several other professional and personal commitments that are taking her time. We appreciate her significant efforts and contributions and wish her the very best.” Ms. Loewen is an accomplished business leader who has held several leadership positions, including at Bell Canada and Air Canada Jazz, as well a

Computershare Acquires CMi2i2.1.2025 13:09:00 EET | Press release

Computershare Limited (ASX: CPU) has announced that it has acquired CMi2i Limited. CMi2i provides independent and trusted advice to boards, executives and advisors of some of the largest public companies around the world. The company’s investor intelligence services, including its bondholder offering, help companies to identify and engage with investors on complex, contested and high stakes issues. It employs around 20 people in London and has a presence in New York, Milan and Madrid. Fiona Chalmers, CEO Issuer Services at Computershare said: “Bringing CMi2i into the Computershare Group is an exciting development that will enhance our investor relations offering to clients. “The acquisition further demonstrates our commitment to giving companies around the world the edge in the increasingly crucial area of shareholder engagement and ownership intelligence. “CMi2i’s approach to capital markets is very well respected, and their services and systems will complement our wider offering very

Aeromexico Named the Most On-Time Global Airline in 2024:2.1.2025 12:00:00 EET | Press release

Cirium, the world’s most trusted source of aviation analytics, today announced the winners of its 2024 On-Time Performance Review, celebrating airlines and airports that excelled in on-time and operational performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250101214982/en/ Cirium On-Time Performance Review 2024 (Photo: Business Wire) Cirium’s Annual report is the gold standard for global airline and airport performance analytics. An on-time flight is defined as a flight that arrives within 14:59 minutes of the scheduled gate arrival time. Airports measure punctuality as departing flights within 14:59 minutes of their scheduled departure time. Mexico’s Flag Carrier Tops Global Rankings Aeromexico claimed the prestigious title of the most On-Time “Global Airline” in 2024, achieving an impressive On-Time performance rate of 86.70%. Saudia followed closely as the runner-up with 86.35%, while Delta Air Lines secured thir

PQE Group Joins Project-COMFORT to Advance Patient-Centric Blood Collection and Diagnostics30.12.2024 08:50:00 EET | Press release

PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic partner in the Project-COMFORT consortium. This innovative public-private partnership, funded by Horizon Europe and supported by the Innovative Health Initiative Joint Undertaking (IHI JU), officially launched in November 2024, marking a transformative shift in blood collection and diagnostics. The ambitious 42-month project brings together 51 organizations from a broad spectrum of sectors, including academia, research institutions, hospitals, foundations, SMEs, medical technology, and pharmaceutical companies, all united by the mission to simplify, reduce the invasiveness of, and increase accessibility to blood collection through cutting-edge, patient-centered microsampling technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241229266268/en/ Follow Project-Comfort LinkedIn Page: https://www.linkedin.

Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range for Surgical and Trauma Wound with SurgiClose® Silicone27.12.2024 21:00:00 EET | Press release

Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of SurgiClose® Silicone, which combines a fish-skin graft and silicone backing for efficient treatment of surgical and trauma wounds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241227975454/en/ SurgiClose® Silicone (Photo: Business Wire) SurgiClose® Silicone is a part of the SurgiClose® product family, which is intact fish-skin intended for the management of trauma wounds and surgical wounds in the operating room. The new product is available in two variations, SurgiClose® Silicone Adhesive with borders that overlap the fish-skin underneath and SurgiClose® Silicone Standard with non-overlapping borders. “Applying Kerecis fish-skin to a surgical or trauma wound is a multi-step process that often requires supporting products such as sutures, st

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye